Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Journal of Medical Screening
|
October 31, 1998
Current state of second trimester screening for Down's syndrome
J A Canick
Prenatal Diagnosis
|
May 29, 1998
The accuracy of assigned risks in maternal serum screening
J A Canick, S Rish
Prenatal Diagnosis
|
July 1, 1992
Maternal serum hCG levels in triploidy: variability and need to consider molar tissue
C E Oyer, J A Canick
Seminars in Perinatology
|
November 7, 1999
First trimester screening for aneuploidy: serum biochemical markers
J A Canick, L H Kellner
Clinical Obstetrics and Gynecology
|
December 1, 1996
Maternal serum screening for fetal Down syndrome: the detection of other pathologies
D N Saller, J A Canick
Medicine and Health, Rhode Island
|
May 23, 1998
Screening for birth defects: integrating laboratory evaluation, genetic counseling and clinical intervention
J A Canick, S R Carr
Clinical Obstetrics and Gynecology
|
December 1, 1996
Maternal serum screening for fetal Down syndrome: clinical aspects
D N Saller, J A Canick
Journal of Medical Screening
|
January 9, 2003
Seeking other disorders within antenatal serum screening programmes for Down's syndrome
N J Wald, J A Canick
Obstetrics and Gynecology Clinics of North America
|
September 1, 1993
Maternal serum screening for aneuploidy and open fetal defects
J A Canick, D N Saller
The Biochemical Journal
|
November 1, 1974
The effect of adrenocorticotrophin on protein degradation in rat adrenal gland and liver
J A Canick, D B Villee
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Journal of Medical Screening
|
October 31, 1998
Current state of second trimester screening for Down's syndrome
J A Canick
Prenatal Diagnosis
|
May 29, 1998
The accuracy of assigned risks in maternal serum screening
J A Canick, S Rish
Prenatal Diagnosis
|
July 1, 1992
Maternal serum hCG levels in triploidy: variability and need to consider molar tissue
C E Oyer, J A Canick
Seminars in Perinatology
|
November 7, 1999
First trimester screening for aneuploidy: serum biochemical markers
J A Canick, L H Kellner
Clinical Obstetrics and Gynecology
|
December 1, 1996
Maternal serum screening for fetal Down syndrome: the detection of other pathologies
D N Saller, J A Canick
Medicine and Health, Rhode Island
|
May 23, 1998
Screening for birth defects: integrating laboratory evaluation, genetic counseling and clinical intervention
J A Canick, S R Carr
Clinical Obstetrics and Gynecology
|
December 1, 1996
Maternal serum screening for fetal Down syndrome: clinical aspects
D N Saller, J A Canick
Journal of Medical Screening
|
January 9, 2003
Seeking other disorders within antenatal serum screening programmes for Down's syndrome
N J Wald, J A Canick
Obstetrics and Gynecology Clinics of North America
|
September 1, 1993
Maternal serum screening for aneuploidy and open fetal defects
J A Canick, D N Saller
The Biochemical Journal
|
November 1, 1974
The effect of adrenocorticotrophin on protein degradation in rat adrenal gland and liver
J A Canick, D B Villee
Page
of 11